局所創傷治療薬の市場規模、シェア、動向分析レポート：製品別、用途別、最終用途別、地域別、セグメント予測、2025年～2030年

局所創傷剤市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の局所創傷剤市場規模は2030年までに28億4,000万米ドルに達すると推定され、2025年から2030年にかけてCAGR 7.74%で成長すると予測されています。

慢性的な傷害の有病率の上昇、外科手術の数の増加、技術的に高度な製品の発売、世界の火傷の症例の増加が市場の主な促進要因です。

局所創傷治療薬は一般に、打撲傷に十分な水分を与え、自己溶解的なデブリードメントを可能にします。慢性的な傷害の有病率の増加と外科手術件数の増加が市場成長の主な促進要因です。例えば、2018年にScienceDirectが発表したレポートによると、外科感染症の有病率は約4.0%と最も高く、次いで糖尿病性足潰瘍が約3.4%となっています。加えて、治癒していない打撲傷を治療するための医療施設が世界中で増加していることも、予測期間中の市場成長を急増させると予想されています。2019年5月、Dalvkot Wound Care（DWC）は、インドのバンガロールに打撲を治療するための初の医療施設を設立し、慢性的な傷害に対する治療法の提供を目指しました。したがって、このような開発は、このような症状に特に使用されるため、局所創傷剤の需要を押し上げる可能性があります。さらに、主要企業による新製品の発売も市場成長にプラスの影響を与える可能性があります。例えば、アーチ・セラピューティクス社（Arch Therapeutics, Inc.）は2019年10月にFDAの承認を取得したAC5　Topical Gelを発売しました。このジェルは、さらなる合併症を引き起こすリスクを最小限に抑えながら、迅速な傷害治癒を可能にします。したがって、このような要因が予測期間中の市場の成長を促進すると予想されます。

局所創傷剤市場レポートハイライト

• クリーム分野は2024年に42.15%と最大の市場シェアを占め、予測期間中に最も急成長が見込まれます。
• 急性創傷セグメントは2024年に最大のシェアを占めました。このセグメントには、外科的・外傷性創傷と火傷が含まれます。
• 病院セグメントは2024年に46.34%の最大シェアを占め、今後数年間で最も急成長すると予測されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 局所創傷治療薬市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
• 市場力学
  • 市場牽引要因分析
  • 市場抑制要因分析
  • 市場機会分析
  • 市場課題分析
• 外用創傷治療薬市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析

第4章 局所創傷治療薬市場：製品の推定・動向分析

• セグメントダッシュボード
• 世界の局所創傷治療薬市場の変動分析
• 世界の局所創傷治療薬市場規模と動向分析、製品別、2018～2030年
• クリーム
• ジェル
• スプレー
• その他

第5章 局所創傷治療薬市場： 用途の推定・動向分析

• セグメントダッシュボード
• 世界の局所創傷治療薬市場の変動分析
• 世界の局所創傷治療薬市場規模と動向分析、用途別、2018～2030年
• 慢性創傷
  • 糖尿病性足潰瘍
  • 褥瘡
  • 静脈性下肢潰瘍
  • その他
• 急性創傷
  • 外科手術および外傷
  • バーンズ

第6章 局所創傷治療薬デバイス：最終用途の推定・動向分析

• セグメントダッシュボード
• 世界の局所創傷治療薬市場の変動分析
• 世界の局所創傷治療薬市場規模と動向分析、最終用途別、2018～2030年
• 病院
  • 病院市場推計・予測2018～2030年
• クリニック
  • クリニック市場推計・予測2018～2030年
• その他
  • その他市場推計・予測2018～2030年

第7章 局所創傷治療薬市場：地域の推定・動向分析

• 地域ダッシュボード
• 市場規模と予測および動向分析、2018年から2030年
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • インド
  • 中国
  • 韓国
  • オーストラリア
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 市場参入企業の分類
• 主要企業プロファイル
  • Smith+Nephew
  • Molnlycke Health Care AB
  • Teva Pharmaceutical Industries Ltd
  • Arch Therapeutics, Inc.
  • Viatris Inc
  • Ipca Laboratories Ltd.
  • Chiesi USA
  • SERDA Therapeutics
• ヒートマップ分析/企業市況分析
• 2024年の企業市場シェアの推定分析
• その他の主要市場企業のリスト

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviation
• Table 3 North America topical wound agents market, by country, 2018 - 2030 (USD Million)
• Table 4 North America topical wound agents market, by product, 2018 - 2030 (USD Million)
• Table 5 North America topical wound agents market, by application, 2018 - 2030 (USD Million)
• Table 6 North America topical wound agents market, by end use, 2018 - 2030 (USD Million)
• Table 7 U.S. topical wound agents market, by product, 2018 - 2030 (USD Million)
• Table 8 U.S. topical wound agents market, by application, 2018 - 2030 (USD Million)
• Table 9 U.S. topical wound agents market, by end use, 2018 - 2030 (USD Million)
• Table 10 Canada topical wound agents market, by product, 2018 - 2030 (USD Million)
• Table 11 Canada topical wound agents market, by application, 2018 - 2030 (USD Million)
• Table 12 Canada topical wound agents market, by end use, 2018 - 2030 (USD Million)
• Table 13 Mexico topical wound agents market, by product, 2018 - 2030 (USD Million)
• Table 14 Mexico topical wound agents market, by application, 2018 - 2030 (USD Million)
• Table 15 Mexico topical wound agents market, by end use, 2018 - 2030 (USD Million)
• Table 16 Europe topical wound agents market, by country, 2018 - 2030 (USD Million)
• Table 17 Europe topical wound agents market, by product, 2018 - 2030 (USD Million)
• Table 18 Europe topical wound agents market, by application, 2018 - 2030 (USD Million)
• Table 19 Europe topical wound agents market, by end use, 2018 - 2030 (USD Million)
• Table 20 UK topical wound agents market, by product, 2018 - 2030 (USD Million)
• Table 21 UK topical wound agents market, by application, 2018 - 2030 (USD Million)
• Table 22 UK topical wound agents market, by end use, 2018 - 2030 (USD Million)
• Table 23 Germany topical wound agents market, by product, 2018 - 2030 (USD Million)
• Table 24 Germany topical wound agents market, by application, 2018 - 2030 (USD Million)
• Table 25 Germany topical wound agents market, by end use, 2018 - 2030 (USD Million)
• Table 26 France topical wound agents market, by product, 2018 - 2030 (USD Million)
• Table 27 France topical wound agents market, by application, 2018 - 2030 (USD Million)
• Table 28 France topical wound agents market, by end use, 2018 - 2030 (USD Million)
• Table 29 Italy topical wound agents market, by product, 2018 - 2030 (USD Million)
• Table 30 Italy topical wound agents market, by application, 2018 - 2030 (USD Million)
• Table 31 Italy topical wound agents market, by end use, 2018 - 2030 (USD Million)
• Table 32 Spain topical wound agents market, by product, 2018 - 2030 (USD Million)
• Table 33 Spain topical wound agents market, by application, 2018 - 2030 (USD Million)
• Table 34 Spain topical wound agents market, by end use, 2018 - 2030 (USD Million)
• Table 35 Denmark topical wound agents market, by product, 2018 - 2030 (USD Million)
• Table 36 Denmark topical wound agents market, by application, 2018 - 2030 (USD Million)
• Table 37 Denmark topical wound agents market, by end use, 2018 - 2030 (USD Million)
• Table 38 Sweden topical wound agents market, by product, 2018 - 2030 (USD Million)
• Table 39 Sweden topical wound agents market, by application, 2018 - 2030 (USD Million)
• Table 40 Sweden topical wound agents market, by end use, 2018 - 2030 (USD Million)
• Table 41 Norway topical wound agents market, by product, 2018 - 2030 (USD Million)
• Table 42 Norway topical wound agents market, by application, 2018 - 2030 (USD Million)
• Table 43 Norway topical wound agents market, by end use, 2018 - 2030 (USD Million)
• Table 44 Asia Pacific topical wound agents market, by country, 2018 - 2030 (USD Million)
• Table 45 Asia Pacific topical wound agents market, by product, 2018 - 2030 (USD Million)
• Table 46 Asia Pacific topical wound agents market, by application, 2018 - 2030 (USD Million)
• Table 47 Asia Pacific topical wound agents market, by end use, 2018 - 2030 (USD Million)
• Table 48 China topical wound agents market, by product, 2018 - 2030 (USD Million)
• Table 49 China topical wound agents market, by application, 2018 - 2030 (USD Million)
• Table 50 China topical wound agents market, by end use, 2018 - 2030 (USD Million)
• Table 51 Japan topical wound agents market, by product, 2018 - 2030 (USD Million)
• Table 52 Japan topical wound agents market, by application, 2018 - 2030 (USD Million)
• Table 53 Japan topical wound agents market, by end use, 2018 - 2030 (USD Million)
• Table 54 India topical wound agents market, by product, 2018 - 2030 (USD Million)
• Table 55 India topical wound agents market, by application, 2018 - 2030 (USD Million)
• Table 56 India topical wound agents market, by end use, 2018 - 2030 (USD Million)
• Table 57 South Korea topical wound agents market, by product, 2018 - 2030 (USD Million)
• Table 58 South Korea topical wound agents market, by application, 2018 - 2030 (USD Million)
• Table 59 South Korea topical wound agents market, by end use, 2018 - 2030 (USD Million)
• Table 60 Australia topical wound agents market, by product, 2018 - 2030 (USD Million)
• Table 61 Australia topical wound agents market, by application, 2018 - 2030 (USD Million)
• Table 62 Australia topical wound agents market, by end use, 2018 - 2030 (USD Million)
• Table 63 Thailand topical wound agents market, by product, 2018 - 2030 (USD Million)
• Table 64 Thailand topical wound agents market, by application, 2018 - 2030 (USD Million)
• Table 65 Thailand topical wound agents market, by end use, 2018 - 2030 (USD Million)
• Table 66 Latin America topical wound agents market, by country, 2018 - 2030 (USD Million)
• Table 67 Latin America topical wound agents market, by product, 2018 - 2030 (USD Million)
• Table 68 Latin America topical wound agents market, by application, 2018 - 2030 (USD Million)
• Table 69 Latin America topical wound agents market, by end use, 2018 - 2030 (USD Million)
• Table 70 Brazil topical wound agents market, by product, 2018 - 2030 (USD Million)
• Table 71 Brazil topical wound agents market, by application, 2018 - 2030 (USD Million)
• Table 72 Brazil topical wound agents market, by end use, 2018 - 2030 (USD Million)
• Table 73 Mexico topical wound agents market, by product, 2018 - 2030 (USD Million)
• Table 74 Mexico topical wound agents market, by application, 2018 - 2030 (USD Million)
• Table 75 Mexico topical wound agents market, by end use, 2018 - 2030 (USD Million)
• Table 76 Argentina topical wound agents market, by product, 2018 - 2030 (USD Million)
• Table 77 Argentina topical wound agents market, by application, 2018 - 2030 (USD Million)
• Table 78 Argentina topical wound agents market, by type, 2018 - 2030 (USD Million)
• Table 79 Middle East & Africa topical wound agents market, by country, 2018 - 2030 (USD Million)
• Table 80 Middle East & Africa topical wound agents market, by product, 2018 - 2030 (USD Million)
• Table 81 Middle East & Africa topical wound agents market, by application, 2018 - 2030 (USD Million)
• Table 82 Middle East & Africa topical wound agents market, by end use, 2018 - 2030 (USD Million)
• Table 83 South Africa topical wound agents market, by product, 2018 - 2030 (USD Million)
• Table 84 South Africa topical wound agents market, by application, 2018 - 2030 (USD Million)
• Table 85 South Africa topical wound agents market, by end use, 2018 - 2030 (USD Million)
• Table 86 Saudi Arabia topical wound agents market, by product, 2018 - 2030 (USD Million)
• Table 87 Saudi Arabia topical wound agents market, by application, 2018 - 2030 (USD Million)
• Table 88 Saudi Arabia topical wound agents market, by end use, 2018 - 2030 (USD Million)
• Table 89 UAE topical wound agents market, by product, 2018 - 2030 (USD Million)
• Table 90 UAE topical wound agents market, by application, 2018 - 2030 (USD Million)
• Table 91 UAE topical wound agents market, by end use, 2018 - 2030 (USD Million)
• Table 92 Kuwait topical wound agents market, by product, 2018 - 2030 (USD Million)
• Table 93 Kuwait topical wound agents market, by application, 2018 - 2030 (USD Million)
• Table 94 Kuwait topical wound agents market, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Information Procurement
• Fig. 2 Primary Research Pattern
• Fig. 3 Market Research Approaches
• Fig. 4 Value Chain-Based Sizing & Forecasting
• Fig. 5 Market Formulation & Validation
• Fig. 6 Topical Wound Agents Market, Market Segmentation
• Fig. 7 Market Driver Analysis (Current & Future Impact)
• Fig. 8 Market Restraint Analysis (Current & Future Impact)
• Fig. 9 Market Opportunity Analysis (Current & Future Impact)
• Fig. 10 Market Challenge Analysis (Current & Future Impact)
• Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 12 Porter's Five Forces Analysis
• Fig. 13 Regional Marketplace: Key Takeaways
• Fig. 14 Global Topical Wound Agents Market, for Product, 2018 - 2030 (USD Million)
• Fig. 15 Global Topical Wound Agents Market, for Creams, , 2018 - 2030 (USD Million)
• Fig. 16 Global Topical Wound Agents Market, for Gels, , 2018 - 2030 (USD Million)
• Fig. 17 Global Topical Wound Agents Market, for Sprays, , 2018 - 2030 (USD Million)
• Fig. 18 Global Topical Wound Agents Market, for Others, , 2018 - 2030 (USD Million)
• Fig. 19 Global Topical Wound Agents Market, for Application, 2018 - 2030 (USD Million)
• Fig. 20 Global Topical Wound Agents Market, for Chronic Wounds, 2018 - 2030 (USD Million)
• Fig. 21 Global Topical Wound Agents Market, for Diabetic Foot Ulcers, 2018 - 2030 (USD Million)
• Fig. 22 Global Topical Wound Agents Market, for Pressure Ulcers, 2018 - 2030 (USD Million)
• Fig. 23 Global Topical Wound Agents Market, for Venous Leg Ulcers, 2018 - 2030 (USD Million)
• Fig. 24 Global Topical Wound Agents Market, for Others, 2018 - 2030 (USD Million)
• Fig. 25 Global Topical Wound Agents Market, for Acute Wounds, 2018 - 2030 (USD Million)
• Fig. 26 Global Topical Wound Agents Market, for Surgical & Traumatic Wounds, 2018 - 2030 (USD Million)
• Fig. 27 Global Topical Wound Agents Market, for Burns, 2018 - 2030 (USD Million)
• Fig. 28 Global Topical Wound Agents Market, for End Use, 2018 - 2030 (USD Million)
• Fig. 29 Global Topical Wound Agents Market, for Hospitals, 2018 - 2030 (USD Million)
• Fig. 30 Global Topical Wound Agents Market, for Clinics, 2018 - 2030 (USD Million)
• Fig. 31 Global Topical Wound Agents Market, for Others, 2018 - 2030 (USD Million)
• Fig. 32 Regional Outlook, 2024 & 2030
• Fig. 33 North America Topical Wound Agents Market, 2018 - 2030 (USD Million)
• Fig. 34 U.S. Topical Wound Agents Market, 2018 - 2030 (USD Million)
• Fig. 35 Canada Topical Wound Agents Market, 2018 - 2030 (USD Million)
• Fig. 36 Mexico Topical Wound Agents Market, 2018 - 2030 (USD Million)
• Fig. 37 Europe Topical Wound Agents Market, 2018 - 2030 (USD Million)
• Fig. 38 Germany Topical Wound Agents Market, 2018 - 2030 (USD Million)
• Fig. 39 UK Topical Wound Agents Market, 2018 - 2030 (USD Million)
• Fig. 40 France Topical Wound Agents Market, 2018 - 2030 (USD Million)
• Fig. 41 Italy Topical Wound Agents Market, 2018 - 2030 (USD Million)
• Fig. 42 Spain Topical Wound Agents Market, 2018 - 2030 (USD Million)
• Fig. 43 Denmark Topical Wound Agents Market, 2018 - 2030 (USD Million)
• Fig. 44 Sweden Topical Wound Agents Market, 2018 - 2030 (USD Million)
• Fig. 45 Norway Topical Wound Agents Market, 2018 - 2030 (USD Million)
• Fig. 46 Asia Pacific Topical Wound Agents Market, 2018 - 2030 (USD Million)
• Fig. 47 Japan Topical Wound Agents Market, 2018 - 2030 (USD Million)
• Fig. 48 China Topical Wound Agents Market, 2018 - 2030 (USD Million)
• Fig. 49 India Topical Wound Agents Market, 2018 - 2030 (USD Million)
• Fig. 50 Australia Topical Wound Agents Market, 2018 - 2030 (USD Million)
• Fig. 51 South Korea Topical Wound Agents Market, 2018 - 2030 (USD Million)
• Fig. 52 Thailand Topical Wound Agents Market, 2018 - 2030 (USD Million)
• Fig. 53 Latin America Topical Wound Agents Market, 2018 - 2030 (USD Million)
• Fig. 54 Brazil Topical Wound Agents Market, 2018 - 2030 (USD Million)
• Fig. 55 Argentina Topical Wound Agents Market, 2018 - 2030 (USD Million)
• Fig. 56 Middle East and Africa Topical Wound Agents Market, 2018 - 2030 (USD Million)
• Fig. 57 South Africa Topical Wound Agents Market, 2018 - 2030 (USD Million)
• Fig. 58 Saudi Arabia Topical Wound Agents Market, 2018 - 2030 (USD Million)
• Fig. 59 UAE Topical Wound Agents Market, 2018 - 2030 (USD Million)
• Fig. 60 Kuwait Topical Wound Agents Market, 2018 - 2030 (USD Million)

Topical Wound Agents Market Growth & Trends:

The global topical wound agents market size is estimated to reach USD 2.84 billion by 2030, registering to grow at a CAGR of 7.74% from 2025 to 2030 according to a new report by Grand View Research, Inc. The rising prevalence of chronic injuries, growing number of surgical procedures, launch of technologically advanced products, and increasing cases of burns globally are the key driving factors for the market.

Topical wound agents generally provide adequate moisture to the bruise and allow autolytic debridement. The increasing prevalence of chronic injuries and rising number of surgical procedures are the key driving factors for market growth. For instance, as per a report published by the ScienceDirect in 2018, surgical infection has highest prevalence rate of around 4.0%, followed by diabetic foot ulcers which are around 3.4%. In addition, rising number of medical facilities for treating unhealed bruises across the globe is also expected to surge market growth over the forecast period. In May 2019, Dalvkot Wound Care (DWC) established the first medical facility for treating bruises in Bangalore, India, which aims to provide remedies to chronic injuries. Thus, such developments may boost the demand for topical wound agents, as they are specifically used for such conditions. Furthermore, new product launches by key players may also positively impact market growth. For instance, Arch Therapeutics, Inc., launched AC5 Topical Gel, which got its FDA approval in October 2019. This gel allows rapid injury healing with minimal risk of getting further complications. Therefore, such factors are anticipated to propel growth of the market over the forecast period.

Topical Wound Agents Market Report Highlights:

• The creams segment held the largest market share, 42.15%, in 2024 and is expected to grow fastest during the forecast period.
• The acute wounds segment held the largest share in 2024. This segment includes surgical & traumatic wounds and burns.
• The hospitals segment held the largest share of 46.34% in 2024 and it is anticipated to witness the fastest growth in the coming years.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
• 1.4. Information or Data Analysis
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Topical Wound Agents Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Rising prevalence of chronic wounds
    • 3.2.1.2. Increasing number of surgeries and trauma cases
    • 3.2.1.3. Advancements in topical wound agents
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Recalls of topical wound agents
  • 3.2.3. Market opportunity analysis
    • 3.2.3.1. Expansion opportunities in emerging economies
    • 3.2.3.2. Clinical trials focusing on topical wound agents
  • 3.2.4. Market challenge analysis
    • 3.2.4.1. Complications and adverse events associated with the use of topical wound agents
• 3.3. Topical Wound Agents Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. Topical Wound Agents Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Topical Wound Agents Market Movement Analysis
• 4.3. Global Topical Wound Agents Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Creams
  • 4.4.1. Creams market estimates and forecast 2018 to 2030 (USD Million)
• 4.5. Gels
  • 4.5.1. Gels market estimates and forecast 2018 to 2030 (USD Million)
• 4.6. Sprays
  • 4.6.1. Sprays market estimates and forecast 2018 to 2030 (USD Million)
• 4.7. Others
  • 4.7.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Topical Wound Agents Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Topical Wound Agents Market Movement Analysis
• 5.3. Global Topical Wound Agents Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Chronic Wounds
  • 5.4.1. Chronic wounds market estimates and forecast 2018 to 2030 (USD Million)
  • 5.4.2. Diabetic foot ulcers
    • 5.4.2.1. Diabetic foot ulcers market estimates and forecast 2018 to 2030 (USD Million)
  • 5.4.3. Pressure ulcers
    • 5.4.3.1. Pressure ulcers market estimates and forecast 2018 to 2030 (USD Million)
  • 5.4.4. Venous leg ulcers
    • 5.4.4.1. Venous leg ulcers market estimates and forecast 2018 to 2030 (USD Million)
  • 5.4.5. Others
    • 5.4.5.1. Others market estimates and forecast 2018 to 2030 (USD Million)
• 5.5. Acute Wounds
  • 5.5.1. Acute wounds market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.2. Surgical & traumatic wounds
    • 5.5.2.1. Surgical & traumatic wounds market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.3. Burns
    • 5.5.3.1. Burns market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Topical Wound Agents Devices: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Topical Wound Agents Market Movement Analysis
• 6.3. Global Topical Wound Agents Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 6.4. Hospitals
  • 6.4.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
• 6.5. Clinics
  • 6.5.1. Clinics market estimates and forecast 2018 to 2030 (USD Million)
• 6.6. Others
  • 6.6.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Topical Wound Agents Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
• 7.3. North America
  • 7.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Competitive scenario
    • 7.3.2.3. Regulatory framework
    • 7.3.2.4. Reimbursement scenario
    • 7.3.2.5. U.S. market estimates and forecasts, 2018 - 2030
  • 7.3.3. Canada
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Competitive scenario
    • 7.3.3.3. Regulatory framework
    • 7.3.3.4. Reimbursement scenario
    • 7.3.3.5. Canada market estimates and forecasts, 2018 - 2030
  • 7.3.4. Mexico
    • 7.3.4.1. Key country dynamics
    • 7.3.4.2. Competitive scenario
    • 7.3.4.3. Regulatory framework
    • 7.3.4.4. Reimbursement scenario
    • 7.3.4.5. Mexico market estimates and forecasts, 2018 - 2030
• 7.4. Europe
  • 7.4.1. UK
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Competitive scenario
    • 7.4.1.3. Regulatory framework
    • 7.4.1.4. Reimbursement scenario
    • 7.4.1.5. UK market estimates and forecasts, 2018 - 2030
  • 7.4.2. Germany
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Competitive scenario
    • 7.4.2.3. Regulatory framework
    • 7.4.2.4. Reimbursement scenario
    • 7.4.2.5. Germany market estimates and forecasts, 2018 - 2030
  • 7.4.3. France
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Competitive scenario
    • 7.4.3.3. Regulatory framework
    • 7.4.3.4. Reimbursement scenario
    • 7.4.3.5. France market estimates and forecasts, 2018 - 2030
  • 7.4.4. Italy
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Competitive scenario
    • 7.4.4.3. Regulatory framework
    • 7.4.4.4. Reimbursement scenario
    • 7.4.4.5. Italy market estimates and forecasts, 2018 - 2030
  • 7.4.5. Spain
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Competitive scenario
    • 7.4.5.3. Regulatory framework
    • 7.4.5.4. Reimbursement scenario
    • 7.4.5.5. Spain market estimates and forecasts, 2018 - 2030
  • 7.4.6. Denmark
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Competitive scenario
    • 7.4.6.3. Regulatory framework
    • 7.4.6.4. Reimbursement scenario
    • 7.4.6.5. Denmark market estimates and forecasts, 2018 - 2030
  • 7.4.7. Sweden
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Competitive scenario
    • 7.4.7.3. Regulatory framework
    • 7.4.7.4. Reimbursement scenario
    • 7.4.7.5. Sweden market estimates and forecasts, 2018 - 2030
  • 7.4.8. Norway
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Competitive scenario
    • 7.4.8.3. Regulatory framework
    • 7.4.8.4. Reimbursement scenario
    • 7.4.8.5. Norway market estimates and forecasts, 2018 - 2030
• 7.5. Asia Pacific
  • 7.5.1. Japan
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Competitive scenario
    • 7.5.1.3. Regulatory framework
    • 7.5.1.4. Reimbursement scenario
    • 7.5.1.5. Japan market estimates and forecasts, 2018 - 2030
  • 7.5.2. India
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Competitive scenario
    • 7.5.2.3. Regulatory framework
    • 7.5.2.4. Reimbursement scenario
    • 7.5.2.5. India market estimates and forecasts, 2018 - 2030
  • 7.5.3. China
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Competitive scenario
    • 7.5.3.3. Regulatory framework
    • 7.5.3.4. Reimbursement scenario
    • 7.5.3.5. China market estimates and forecasts, 2018 - 2030
  • 7.5.4. South Korea
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Competitive scenario
    • 7.5.4.3. Regulatory framework
    • 7.5.4.4. Reimbursement scenario
    • 7.5.4.5. South Korea market estimates and forecasts, 2018 - 2030
  • 7.5.5. Australia
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Competitive scenario
    • 7.5.5.3. Regulatory framework
    • 7.5.5.4. Reimbursement scenario
    • 7.5.5.5. Australia market estimates and forecasts, 2018 - 2030
  • 7.5.6. Thailand
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Competitive scenario
    • 7.5.6.3. Regulatory framework
    • 7.5.6.4. Reimbursement scenario
    • 7.5.6.5. Thailand market estimates and forecasts, 2018 - 2030
• 7.6. Latin America
  • 7.6.1. Brazil
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Competitive scenario
    • 7.6.1.3. Regulatory framework
    • 7.6.1.4. Reimbursement scenario
    • 7.6.1.5. Brazil market estimates and forecasts, 2018 - 2030
  • 7.6.2. Argentina
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Competitive scenario
    • 7.6.2.3. Regulatory framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. Argentina market estimates and forecasts, 2018 - 2030
• 7.7. MEA
  • 7.7.1. South Africa
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Competitive scenario
    • 7.7.1.3. Regulatory framework
    • 7.7.1.4. Reimbursement scenario
    • 7.7.1.5. South Africa market estimates and forecasts, 2018 - 2030
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Competitive scenario
    • 7.7.2.3. Regulatory framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
  • 7.7.3. UAE
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Competitive scenario
    • 7.7.3.3. Regulatory framework
    • 7.7.3.4. Reimbursement scenario
    • 7.7.3.5. UAE market estimates and forecasts, 2018 - 2030
  • 7.7.4. Kuwait
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Competitive scenario
    • 7.7.4.3. Regulatory framework
    • 7.7.4.4. Reimbursement scenario
    • 7.7.4.5. Kuwait market estimates and forecasts, 2018 - 2030

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
  • 8.2.1. Smith+Nephew
    • 8.2.1.1. Company overview
    • 8.2.1.2. Financial performance
    • 8.2.1.3. Product benchmarking
    • 8.2.1.4. Strategic initiatives
  • 8.2.2. Molnlycke Health Care AB
    • 8.2.2.1. Company overview
    • 8.2.2.2. Financial performance
    • 8.2.2.3. Product benchmarking
    • 8.2.2.4. Strategic initiatives
  • 8.2.3. Teva Pharmaceutical Industries Ltd
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Product benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. Arch Therapeutics, Inc.
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Product benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. Viatris Inc
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Product benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. Ipca Laboratories Ltd.
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Product benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. Chiesi USA
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Product benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. SERDA Therapeutics
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Product benchmarking
    • 8.2.8.4. Strategic initiatives
• 8.3. Heat Map Analysis/ Company Market Position Analysis
• 8.4. Estimated Company Market Share Analysis, 2024
• 8.5. List of Other Key Market Players